單細胞體學：新興技術與市場

全球單細胞基因體學和蛋白質體學市場規模預計將從2024年的40億美元成長到2029年底的91億美元，預測期內的年複合成長率為 17.6%。

預計北美市場將從2024年的19億美元成長到2029年終的43億美元，預測期內的年複合成長率為 17.8%。預計亞太地區將從2024年的8.872億美元成長到2029年終的20億美元，年複合成長率為 18.1%。

本報告調查了全球單細胞體學市場，並提供了市場概況的摘要、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展的趨勢、市場規模的趨勢和預測、各個細分市場和地區的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 執行摘要

• 市場展望
• 研究範圍
• 市場摘要

第2章 市場概述

• 概述
• 技術背景
• 體學類型
• 技術基礎設施和資料整合
• 宏觀經濟因素分析
• 持續的俄烏戰爭對單細胞基因體學和蛋白質體學市場的影響
• 經濟不確定性和研究經費削減
• 營運成本增加
• 改變地緣政治合作
• 俄羅斯與技術出口制裁
• 波特五力分析

第3章 監管情況

• 監管概述
• 各國/地區市場法規
• 聯邦法規
• CMS法規
• FDA法規
• 聯邦貿易委員會監管
• 加拿大
• EU
• 英國
• 中國
• 日本
• 澳洲
• 國際標準和指南

第4章 市場動態

• 市場動態
• 市場促進因素
• 增加對單細胞基因組學和蛋白質組學研究活動的投資和資金
• 癌症發生率上升導致個人化治療需求增加
• 單細胞基因體學和蛋白質體學在藥物開發過程中的有前景的應用
• 市場限制
• 單細胞蛋白質體高成本
• 技術挑戰
• 市場機會
• 單細胞研究的技術進步與自動化
• 合作與夥伴關係

第5章 新興技術與發展

• 單細胞基因組學和蛋白質組學中的人工智慧
• AI單細胞基因組學和蛋白質組學市場中的公司
• 單體學和多體學的進展

第6章 市場區隔分析

• 市場概覽
• 細分市場
• 全球單細胞基因體學和蛋白質體學市場（依檢測類型）
• 單細胞基因體學
• 單細胞蛋白質體學
• 單細胞轉錄組學
• 單細胞表觀基因
• 全球單細胞基因體學和蛋白質體學市場（依應用）
• 瘤
• 幹細胞生物學
• 免疫
• 其他
• 全球單細胞基因組學和蛋白質組學市場（依最終用戶）
• 學術研究所
• 生物製藥和生物技術公司
• 臨床實驗室
• 應用市場
• 地理分佈
• 單細胞基因組學和蛋白質組學市場（依地區）
• 北美洲
• 歐洲
• 亞太地區
• 其他地區

第7章 競爭訊息

• 概述
• 主要企業排名
• 公司採用的關鍵策略
• 合作與夥伴關係
• 新產品發布
• 擴張與投資
• M&A
• 專利分析
• 摘要

第8章 基因組學和蛋白質組學市場的永續性：ESG 視角

• ESG介紹
• 市場中的ESG 表現
• 基因組學和蛋白質組學行業的ESG 實踐
• 環境績效
• 社會績效
• 管治績效
• ESG風險評估
• BCC的結語

第9章 附錄

• 調查方法
• 簡稱
• 公司簡介
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.

The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.

The North American market for single-cell genomics and proteomics is expected to grow from $1.9 billion in 2024 to reach $4.3 billion by the end of 2029, at a CAGR of 17.8% from 2024 through 2029.

The Asia-Pacific market for single-cell genomics and proteomics is expected to grow from $887.2 million in 2024 to reach $2.0 billion by the end of 2029, at a CAGR of 18.1% from 2024 through 2029.

Report Scope:

The report highlights the current and future market potential of single-cell genomics and proteomics and a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections for 2029, including a competitive environment and product analysis. The report provides market estimates and forecasts for single-cell genomics and proteomics based on analysis type, application, end user and region. Based on product type, the market is segmented into single-cell genomics, single-cell epigenomics and single-cell transcriptomics. The market is categorized as academic and research organizations, biopharmaceutical and biotechnology companies, and applied markets and clinical laboratories based on end user. The market is segmented into stem cell biology, oncology, immunology, microbiology and others based on application.

The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios and recent developments. By geography, the market has been organized into North America, Europe, Asia-Pacific and the Rest of the World (RoW). The North American region includes countries such as the U.S., Canada and Mexico. Europe includes Germany, the UK, Italy, France, Spain and the rest of Europe; Asia-Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia-Pacific. The Rest of the World includes South America and the Middle East and Africa. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Report Includes:

• 43 data tables and 59 additional tables
• An overview of the global markets and emerging technologies for single-cell genomics and proteomics
• Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of and forecast for the overall market for single-cell genomics and proteomics, and quantification of the market potential by analysis type, application, end user and region
• Description of cell isolation technologies, including flow cytometry, laser capture microscopy and micromanipulation, and sample preparation technologies, including microfluidics and whole genome amplification/pre-amplification
• Coverage of NGS, qPCR/PCR, microarrays, mass spectrometry and microfluidics
• Discussion of the major market dynamics and shifts, and the regulations, industry challenges, and macroeconomic factors that will affect the single-cell genomics and proteomics market over the coming years
• Review of the patent filings and research publications for innovations in single-cell genomics and proteomics technology
• A discussion of the industry's ESG challenges and practices
• Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
• Insight into industry structure, competitive landscape, clinical trials and ongoing research activity
• Profiles of the major players, including 10x Genomics, Thermo Fisher Scientific Inc., Illumina Inc., BD and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Technology Background
• Types of Omics
• Technological Infrastructure and Data Integration
• Macroeconomic Factors Analysis
• Impact of Ongoing Russia-Ukraine War on the Single-cell Genomics and Proteomics Market
• Economic Uncertainty and Research Funding Cuts
• Increased Operational Costs
• Shift in Geopolitical Collaborations
• Sanctions on Russia and Technology Exports
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential of New Entrants
• Competition in the Industry
• Threat of Substitutes

Chapter 3 Regulatory Landscape

• Regulatory Overview
• Market Regulations by Country/Region
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• United Kingdom (U.K.)
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 4 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Investment and Funding for Single-cell Genomics and Proteomics Research Activities
• Growing Prevalence of Cancer Generating Demand for Personalized Treatments
• Promising Applications of Single-cell Genomics and Proteomics in the Drug Development Process
• Market Restraints
• High Costs Associated with Single-cell Proteomics
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in Single-cell Studies
• Collaboration and Partnerships

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Single-cell Genomics and Proteomics
• Companies in the AI Single-cell Genomics and Proteomics Market
• Advances in Single-cell Omics and Multi-omics

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Single-cell Genomics and Proteomics Market by Analysis Type
• Single-cell Genomics
• Single-cell Proteomics
• Single-cell Transcriptomics
• Single-cell Epigenomics
• Global Single-cell Genomics and Proteomics Market by Application
• Oncology
• Stem Cell Biology
• Immunology
• Other Applications
• Global Single-cell Genomics and Proteomics Market by End User
• Academic and Research Organizations
• Biopharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Applied Markets
• Geographic Breakdown
• Global Single-cell Genomics and Proteomics Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Overview
• Top Players Ranking
• Key Strategies Adopted by Players
• Collaborations and Partnerships
• New Product Launches
• Expansions and Investments
• Mergers and Acquisitions
• Patent Analysis
• Takeaways

Chapter 8 Sustainability in the Genomics and Proteomics Market: ESG Perspective

• Introduction to ESG
• ESG Performance in the Market
• ESG Practices in the Genomics and Proteomics Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• 10X GENOMICS
• AGILENT TECHNOLOGIES INC.
• BD
• BIO-RAD LABORATORIES INC.
• BIO-TECHNE
• BRUKER
• F. HOFFMANN-LA ROCHE LTD.
• ILLUMINA INC.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• SARTORIUS AG
• STANDARD BIOTOOLS
• TECAN TRADING AG
• THERMO FISHER SCIENTIFIC INC.

List of Tables

• Summary Table : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
• Table 1 : Molecular Biology Technologies for Multi-omics Approaches
• Table 2 : Single-cell and Spatial Omics Technologies, 2018-2023
• Table 3 : Companies in the AI Single-cell Genomics and Proteomics Market
• Table 4 : Global Single-cell Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 5 : Global Single-cell Genomics Market, by Region, Through 2029
• Table 6 : Global Single-cell Proteomics Market, by Region, Through 2029
• Table 7 : Global Single-cell Transcriptomics Market, by Region, Through 2029
• Table 8 : Global Single-cell Epigenomics Market, by Region, Through 2029
• Table 9 : Global Single-cell Genomics and Proteomics Market, by Application, Through 2029
• Table 10 : Global Single-cell Genomics and Proteomics Market for Oncology, by Region, Through 2029
• Table 11 : Global Single-cell Genomics and Proteomics Market for Stem Cell Biology, by Region, Through 2029
• Table 12 : Global Single-cell Genomics and Proteomics Market for Immunology, by Region, Through 2029
• Table 13 : Global Single-cell Genomics and Proteomics Market for Other Applications, by Region, Through 2029
• Table 14 : Global Single-cell Genomics and Proteomics Market, by End User, Through 2029
• Table 15 : Global Single-cell Genomics and Proteomics Market for Academic and Research Organizations, by Region, Through 2029
• Table 16 : Global Single-cell Genomics and Proteomics Market for Biopharmaceutical and Biotechnology Companies, by Region, Through 2029
• Table 17 : Global Single-cell Genomics and Proteomics Market for Clinical Laboratories, by Region, Through 2029
• Table 18 : Global Single-cell Genomics and Proteomics Market for Applied Markets, by Region, Through 2029
• Table 19 : Global Single-cell Genomics and Proteomics Market, by Region, Through 2029
• Table 20 : North American Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 21 : North American Genomics and Proteomics Market, by Application, Through 2029
• Table 22 : North American Genomics and Proteomics Market, by End User, Through 2029
• Table 23 : European Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 24 : European Genomics and Proteomics Market, by Application, Through 2029
• Table 25 : European Genomics and Proteomics Market, by End User, Through 2029
• Table 26 : Asia-Pacific Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 27 : Asia-Pacific Genomics and Proteomics Market, by Application, Through 2029
• Table 28 : Asia-Pacific Genomics and Proteomics Market, by End User, Through 2029
• Table 29 : RoW Genomics and Proteomics Market, by Analysis Type, Through 2029
• Table 30 : RoW Genomics and Proteomics Market, by Application, Through 2029
• Table 31 : RoW Genomics and Proteomics Market, by End User, Through 2029
• Table 32 : Top Players in the Single-cell Genomics and Proteomics Market, 2023
• Table 33 : Collaborations and Partnerships: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 34 : New Product Launch: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 35 : Expansions and Investments: Single-cell Genomics and Proteomics Market, 2021-2024
• Table 36 : Mergers and Acquisitions: Single-cell Genomics and Proteomics Market, 2020-2024
• Table 37 : Single-cell Genomics and Proteomics Market: Patent Analysis, 2018-2024
• Table 38 : Key Focus Areas in ESG Metrics
• Table 39 : Environmental Performance Initiatives in the Genomics and Proteomics Market
• Table 40 : Social Performance Initiatives in the Genomics and Proteomics Market
• Table 41 : Governance Performance Initiatives in the Genomics and Proteomics Market
• Table 42 : ESG Rankings for Genomics and Proteomics Companies, 2024*
• Table 43 : Abbreviations Used in this Report
• Table 44 : 10x Genomics: Company Snapshot
• Table 45 : 10x Genomics: Financial Performance, FY 2022 and 2023
• Table 46 : 10x Genomics: Product Portfolio
• Table 47 : 10x Genomics: News/Key Developments, 2024
• Table 48 : Agilent Technologies Inc.: Company Snapshot
• Table 49 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 50 : Agilent Technologies Inc.: Product Portfolio
• Table 51 : Agilent Technologies Inc.: News/Key Developments, 2023
• Table 52 : BD: Company Snapshot
• Table 53 : BD: Financial Performance, FY 2023 and 2024
• Table 54 : BD: Product Portfolio
• Table 55 : BD: News/Key Developments, 2023-2024
• Table 56 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 57 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
• Table 58 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 59 : Bio-Rad Laboratories Inc.: News/Key Developments, 2024
• Table 60 : Bio-Techne: Company Snapshot
• Table 61 : Bio-Techne: Financial Performance, FY 2022 and 2023
• Table 62 : Bio-Techne: Product Portfolio
• Table 63 : Bio-Techne: News/Key Developments, 2022
• Table 64 : Bruker: Company Snapshot
• Table 65 : Bruker: Financial Performance, FY 2022 and 2023
• Table 66 : Bruker: Product Portfolio
• Table 67 : Bruker: News/Key Developments, 2024
• Table 68 : F. Hoffmann-La Roche Ltd.: Company Snapshot
• Table 69 : F. Hoffman-La Roche Ltd.: Financial Performance, FY 2022 and 2023
• Table 70 : F. Hoffman-La Roche Ltd.: Product Portfolio
• Table 71 : F. Hoffman-La Roche Ltd.: News/Key Developments, 2021-2022
• Table 72 : Illumina Inc.: Company Snapshot
• Table 73 : Illumina Inc.: Financial Performance, FY 2022 and 2023
• Table 74 : Illumina Inc.: Product Portfolio
• Table 75 : Illumina Inc.: News/Key Developments, 2022-2023
• Table 76 : Merck KGaA: Company Snapshot
• Table 77 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 78 : Merck KGaA: Product Portfolio
• Table 79 : Promega Corp.: Company Snapshot
• Table 80 : Promega Corp.: Product Portfolio
• Table 81 : Promega Corp.: News/Key Developments, 2022-2023
• Table 82 : Qiagen: Company Snapshot
• Table 83 : Qiagen: Financial Performance, FY 2022 and 2023
• Table 84 : Qiagen: Product Portfolio
• Table 85 : Qiagen: News/Key Developments, 2022-2024
• Table 86 : Sartorius AG: Company Snapshot
• Table 87 : Sartorius AG: Financial Performance, FY 2022 and 2023
• Table 88 : Sartorius AG: Product Portfolio
• Table 89 : Sartorius AG: News/Key Developments, 2024
• Table 90 : Standard BioTools: Company Snapshot
• Table 91 : Standard BioTools: Financial Performance, FY 2022 and 2023
• Table 92 : Standard BioTools: Product Portfolio
• Table 93 : Standard BioTools: News/Key Developments, 2022-2024
• Table 94 : Tecan Trading AG: Company Snapshot
• Table 95 : Tecan Trading AG: Financial Performance, FY 2022 and 2023
• Table 96 : Tecan Trading AG: Product Portfolio
• Table 97 : Tecan Trading AG: News/Key Developments, 2024
• Table 98 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 99 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 100 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 101 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2024

List of Figures

• Summary Figure : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
• Figure 1 : Types of Omics
• Figure 2 : Porter's Five Forces Analysis for the Single-cell Genomics and Proteomics Market
• Figure 3 : Market Dynamics of Single-cell Genomics and Proteomics
• Figure 4 : Global Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 5 : Global Single-cell Genomics Market Share, by Region, 2023
• Figure 6 : Global Single-cell Proteomics Market Share, by Region, 2023
• Figure 7 : Global Single-cell Transcriptomics Market Share, by Region, 2023
• Figure 8 : Global Single-cell Epigenomics Market Share, by Region, 2023
• Figure 9 : Global Single-cell Genomics and Proteomics Market Share, by Application, 2023
• Figure 10 : Global Single-cell Genomics and Proteomics Market Share, by End User, 2023
• Figure 11 : Global Single-cell Genomics and Proteomics Market Share, by Region, 2023
• Figure 12 : North American Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 13 : European Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 14 : Asia-Pacific Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 15 : RoW Single-cell Genomics and Proteomics Market Share, by Analysis Type, 2023
• Figure 16 : Snapshot of ESG Pillars
• Figure 17 : Advantages of ESG for Companies
• Figure 18 : Share of Biotech Companies Providing ESG Disclosure, 2022
• Figure 19 : Share of ESG Disclosure Location for the Biotech Companies, 2022
• Figure 20 : 10x Genomics: Revenue Share, by Business Unit, FY 2023
• Figure 21 : 10x Genomics: Revenue Share, by Country/Region, FY 2023
• Figure 22 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 23 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 24 : BD: Revenue Share, by Business Unit, FY 2024
• Figure 25 : BD: Revenue Share, by Country/Region, FY 2024
• Figure 26 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 27 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
• Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
• Figure 30 : Bruker: Revenue Share, by Business Unit, FY 2023
• Figure 31 : Bruker: Revenue Share, by Country/Region, FY 2023
• Figure 32 : F. Hoffman-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
• Figure 33 : F. Hoffman-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
• Figure 34 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 35 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023
• Figure 36 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
• Figure 37 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
• Figure 38 : Qiagen: Revenue Share, by Business Unit, FY 2023
• Figure 39 : Qiagen: Revenue Share, by Country/Region, FY 2023
• Figure 40 : Sartorius AG: Revenue Share, by Business Unit, FY 2023
• Figure 41 : Sartorius AG: Revenue Share, by Country/Region, FY 2023
• Figure 42 : Standard BioTools: Revenue Share, by Business Unit, FY 2023
• Figure 43 : Standard BioTools: Revenue Share, by Country/Region, FY 2023
• Figure 44 : Tecan Trading AG: Revenue Share, by Business Unit, FY 2023
• Figure 45 : Tecan Trading AG: Revenue Share, by Country/Region, FY 2023
• Figure 46 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
• Figure 47 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023